C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation

Circulation

Volumn 104, Issue 24, 2001, Pages 2886-2891

  Chung, Mina K ^a   Martin, David O ^a   Sprecher, Dennis ^a   Wazni, Oussama ^a   Kanderian, Anne ^a   Carnes, Cynthia A ^b   Bauer, John A ^b   Tchou, Patrick J ^a   Niebauer, Mark J ^a   Natale, Andrea ^a   Van Wagoner, David R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Arrhythmia; C reactive protein; Fibrillation; Inflammation

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; SINUS RHYTHM; STROKE; SUPRAVENTRICULAR PREMATURE BEAT;

EID: 0035846667     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4901.101760     Document Type: Article

References (30)

1. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
2. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy
3. Tachycardia-related cardiomyopathy: A common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation
4. Atrial enlargement as a consequence of atrial fibrillation: A prospective echocardiographic study
5. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation
6. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation
7. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation
8. Atrial L-type Ca2+ currents and human atrial fibrillation
9. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia
10. Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia
11. Histological substrate of atrial biopsies in patients with lone atrial fibrillation
12. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
13. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
14. Clinical efficacy of an automated high-sensitivity C-reactive protein assay
15. Bone formation and inflammation in cardiac valves
16. Angiotensin, inflammation, hypertension, and cardiovascular disease
17. The role of nonpharmacologic therapies for the treatment of atrial fibrillation
18. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
19. Novel inflammatory markers of coronary risk: Theory versus practice
20. Acute-phase proteins and other systemic responses to inflammation
21. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
22. Direct proinflammatory effect of C-reactive protein on human endothelial cells
23. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
24. Long-term effects of pravastatin on plasma concentration of C-reactive protein: The Cholesterol and Recurrent Events (CARE) Investigators
25. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia
26. Effect of statins on C-reactive protein in patients with coronary artery disease
27. A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial)
28. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
29. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes
30. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients